Compare BIRK & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIRK | CHE |
|---|---|---|
| Founded | 1774 | 1970 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 6.2B |
| IPO Year | 2023 | N/A |
| Metric | BIRK | CHE |
|---|---|---|
| Price | $42.40 | $433.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $67.09 | ★ $574.25 |
| AVG Volume (30 Days) | ★ 2.5M | 140.9K |
| Earning Date | 12-18-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | ★ 83.33 | N/A |
| EPS | 2.19 | ★ 18.95 |
| Revenue | $2,460,904,611.00 | ★ $2,530,634,000.00 |
| Revenue This Year | $16.09 | $5.91 |
| Revenue Next Year | $15.69 | $6.21 |
| P/E Ratio | ★ $18.75 | $22.70 |
| Revenue Growth | ★ 16.22 | 6.45 |
| 52 Week Low | $38.16 | $408.42 |
| 52 Week High | $62.66 | $623.61 |
| Indicator | BIRK | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 52.54 |
| Support Level | $42.38 | $425.50 |
| Resistance Level | $48.16 | $435.36 |
| Average True Range (ATR) | 1.85 | 7.98 |
| MACD | -0.15 | 1.09 |
| Stochastic Oscillator | 29.60 | 77.61 |
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.